ViewRay® to Present at the Stifel 2022 Healthcare Conference

Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) announced it will present at the Stifel 2022 Healthcare Conference. The presentation will feature CEO Scott Drake and CFO Zach Stassen in a fireside chat scheduled for 2:25 p.m. ET on November 15, 2022. An audio webcast will be available on the investor relations section of ViewRay's website, with a replay accessible for 7 days post-presentation. ViewRay designs and markets the MRIdian MRI-Guided Radiation Therapy System, which addresses unique challenges in radiation oncology.

News Market Reaction – VRAY

+4.87%

+4.87% Session move

In the trading session that priced this news, VRAY gained 4.87%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, Nov. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Stifel 2022 Healthcare Conference. Scott Drake, President and Chief Executive Officer, and Zach Stassen, Chief Financial Officer, will participate in a fireside chat at 2:25 p.m. Eastern Time on Tuesday, November 15, 2022.

An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at https://investors.viewray.com/events-and-webinars. A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian^® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc. 

 

View original content:https://www.prnewswire.com/news-releases/viewray-to-present-at-the-stifel-2022-healthcare-conference-301672772.html

SOURCE ViewRay, Inc.

FAQ

When is ViewRay's presentation at the Stifel 2022 Healthcare Conference?

ViewRay's presentation is scheduled for 2:25 p.m. ET on November 15, 2022.

Who will represent ViewRay at the Stifel 2022 Healthcare Conference?

Scott Drake, the CEO, and Zach Stassen, the CFO, will represent ViewRay.

Where can I listen to the ViewRay presentation?

The presentation can be accessed via an audio webcast on ViewRay's investor relations website.

How long will the audio replay of ViewRay's presentation be available?

The audio replay will be available for 7 days after the presentation.

What products does ViewRay manufacture?

ViewRay manufactures the MRIdian MRI-Guided Radiation Therapy System.